Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $4.3100 (-1.6%) ($4.3000 - $4.3100) on Fri. Dec. 31, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.71% (three month average) | RSI | 50 | Latest Price | $4.3100(-1.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.2% a day on average for past five trading days. | Weekly Trend | CGEN advances 0.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(84%) ARKG(81%) ARKK(80%) IBUY(79%) IWO(78%) | Factors Impacting CGEN price | CGEN will decline at least -2.355% in a week (0% probabilities). VIXM(-67%) VXX(-51%) UUP(-18%) UNG(-15%) TLT(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.355% (StdDev 4.71%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $4.34 | 5 Day Moving Average | $4.28(0.7%) | 10 Day Moving Average | $4.37(-1.37%) | 20 Day Moving Average | $4.34(-0.69%) | To recent high | -39.8% | To recent low | 5.9% | Market Cap | $356m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |